The first CT antigen, melanoma antigen (MAGE)-1—now known as MAGEA1—was discovered in 1991 using autologous typing, a technique in which tumor cells from a patient are co-cultured with autologous lymphocytes to test for the generation of T cells that target tumor antigens [10,12,13]. This evidence concerns the gene MAGEA1 and neoplasm.